Medpace Holdings, Inc. (NasdaqGS: MEDP)
Health Care · Life Sciences Tools & Services · US
$620.75
+1.28% today · +36.9% 1Y
Medpace Holdings, Inc. (NasdaqGS: MEDP) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $17.33B and employs 6,500 people.
Over the last twelve months the share price has gained 36.9%, trading between 373.00 and 677.90.
Tweenvest scores Medpace Holdings, Inc. across four factors: quality 91/100, value 25/100, growth 91/100. Its strongest factor is quality.
MEDP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.33B
- Revenue (TTM)
- $2.78B
- P/E
- 36.39
- EPS
- 17.06
- Dividend yield
- —
- Beta (5Y)
- 1.15
- 52-week high
- $677.90
- 52-week low
- $373.00
- Avg volume (3M)
- —
- Shares outstanding
- 27.91M
- Employees
- 6,500
- Next earnings
- —
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- ISIN
- US58506Q1094
- Founded
- 1992
- Listed since
- Aug 11, 2016
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.